Gerald Boyd, the first black managing editor of The New York Times, the man forced to resign two years after his appointment -- during a reporter's plagiarism scandal -- died Thursday of lung cancer. He was 56.

Boyd was diagnosed with cancer in February and while he was sick for most of the year, he kept his condition private from most friends and colleagues.

Boyd is credited for his ability to mobilize a reporting team and surround a story to capture every important fact. He was tough and demanding and had a huge heart. And while he left the paper under sad circumstances, he also left as a well-respected newsman.

Boyd became managing editor in 2001 and resigned in 2003 after the discovery that reporter Jayson Blair had plagiarized material, invented quotes, and wrote stories using datelines of places he'd never seen. The scandal resulted in discontented staff members who lost confidence in Boyd's leadership.

After his resignation, Boyd became involved in several projects and found himself writing a column for Universal Press Syndicate. His goal -- to help people understand how newsroom decisions are made.

Boyd is survived by his wife and 10-year-old son.

Some campaigns just make me sad. UK's Age Concern, a charity that works to promote the health and welfare of older citizens, has launched a campaign called Hungry To Be Heard because it seems nine of of ten nurses do not have time to make sure elderly patients are getting enough to eat during their stay in the hospital. As a result, over half of the elderly patients are at risk for malnutrition. As hospital patients, if the elderly are malnourished, they simply are not going to recover or heal as quickly; they are at greater risk for post-surgical complications and they suffer a higher rate of death.

I feel fortunate to have received every cancer drug I needed to fight my breast cancer -- Adriamycin, Cytoxan, Herceptin, and every nausea pill, pain capsule, and anti-anxiety formula on the market. I got exactly what doctors thought I needed -- without worry about availability or funding or politics. I am lucky. Some in the UK are not so lucky.

Two targeted therapies for bowel cancer will not be used in Britain's state-run health system, according to NICE -- the National Institute for Health and Clinical Excellence. NICE, the country's financial watchdog, determined the high cost of the medicines meant their use was not compatible with the best use of resources. Patients are angry because these same two drugs -- Avastin and Erbitux -- are used widely in the United States and in much of Europe. And while neither drug offers a cure for bowel cancer, both treatments have been shown in clinical trials to extend life expectancy by four or five months in some patients.

Based on doses given during the trials, it is estimated that the average cost of treating one patient with Avastin would be around 16,800 pounds and with Erbitux -- about 11,700 pounds. Apparently, this is too much. But according to Hilary Whittaker of the charity Beating Bowel Cancer, the decision to deprive patients of this medication is a scandal. I agree. And for these patients, I am sad.

We recently posted Elephant Man drug trial victim showing signs of cancer, about a horrific ordeal involving six healthy young men who volunteered at Northwick Park Hospital, in London as participants in a clinical trial for a drug called TGN1412, designed to treat leukemia, autoimmune and inflammatory diseases.

According to the men, they were told by doctors there would be no serious short-term or long-term side effects from participating in the drug trial. That wasn't the case. The participants were misled regarding the safety of the experimental drug -- everything went terribly wrong -- and one of the six men has now been told he is showing signs of cancer.

Another egregious event has occurred on the other side of the pond, according to news of an allegation made by a woman who claims she was used as an experimental cancer drug guinea pig without consent.

The story began last year when Trelene Cave was diagnosed with ovarian cancer. Treated at Epsom General Hospital and the Royal Marsden Hospital in Sutton, she was later sent to St George's Hospital for a second opinion before undergoing an operation. The trouble begins when St George's Hospital doctors allegedly treated Cave with Scotroc4, an experimental cancer drug, without her informed consent. She developed a blood clot and almost died.

Cave states in the news report that, "I trusted them totally. Nobody discussed it with me. I just can't understand it."

St George's Healthcare Trust has apologized to her and her husband Norman for the incident. An investigation has been called for into whether St George's Hospital doctors side-stepped ethical guidelines in treating Cave without her knowledge.

Thanks to Joel Arellano of Autoblog for this story tip!

In a universal health system, care is rationed by medical priority when determining where health dollars will be spent and what types of treatment will be covered. In the UK, a debate is taking place between British scientists who are recommending that unproven or disproved complementary therapies not be funded and therapists of complementary medicine who argue that many of the alternative therapies have been proven effective and should be funded for patients who can benefit from such therapies. This has opened up a whole new discussion in defining exactly what alternative or complementary therapies are and what place they have in modern medical practice.

Meanwhile, Prince Charles, a strong advocate of alternative therapies and organic foods, spoke to World Health Assembly members of the World Health Organization about the need to consider making better use of traditional therapies, particularly acupuncture and herbal medicines, to improve health care around the world.

"I believe that the proper mix of proven complementary, traditional and modern remedies, which emphasizes the active participation of the patient, can help to create a powerful healing force in the world,'' Charles said. "This is where orthodox practice can learn from complementary medicine, the West can learn from the East and new from old traditions."

Prince Charles is concerned that if we do not recognize the wisdom and value of the past, much of that knowledge will be lost. Putting aside politics, monarchy and scandal, I am gaining more respect for the Prince of Wales the more I learn about his perspectives concerning health and the environment.

Exactly what I was thinking yesterday - saying "Sorry" just isn't good enough. A woman named Mina Braniff, from Northern Ireland, who is unfortunately involved in the scandal where 18 women were falsely cleared of breast cancer is demanding more from her government. Rightfully so, eight days of agonising waiting, to find out she had been wrongly diagnosed three years ago. Her imagination was getting the best of her for more than a week as she was wondering how far has the cancer spread in 3 years. I can't even imagine Mina's anguish, anxiety, and distress. She has finally been told she is in the clear, but 14 women were not so lucky. They are now receiving the care they need, I hope it isn't to late for these individuals. Please keep the women from all cases similiar in your thoughts as they continue to go through this arduous ordeal.